Search

Author/Creator Vaissiere, Nathalie

1. Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials. Issue 32 (30th July 2022)

Authors:
Sadoff, Jerald; Le Gars, Mathieu; Brandenburg, Boerries; Cárdenas, Vicky; Shukarev, Georgi; Vaissiere, Nathalie; Heerwegh, Dirk; Truyers, Carla; de Groot, Anne Marit; Jongeneelen, Mandy; Kaszas, Krisztian; Tolboom, Jeroen; Scheper, Gert; Hendriks, Jenny; Ruiz-Guiñazú, Javier; Struyf, Frank; Van H...
Journal:
Vaccine
Issue:
Volume 40:Issue 32(2022)
Page Start:
4403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 12(2022)
Page Start:
1703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search